drugset / Trial / NCT01150162

Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

NCT01150162

Phase 3 Completed 129 enrolled Otsuka Pakistan Limited
RandomizedParallel-groupOpen-labelTreatment

Summary

A Prospective Randomized, Multi-center study to assess the Safety and Efficacy of Mucosta (Rebamipide), in combination with Omeprazole as adjuvant therapy in Gastric Ulcer Patients.

Timeline

Start
2010-10
Primary completion
2012-06
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 20 mg Oral
Subject Rebamipide Small molecule 100 mg Oral

Indications